Download PDF
Go back to website
If you have problems to see the content please click here
Other users also viewed these articles
Strategies for reducing cardiovascular mortality should go beyond control of classic risk factors
Marcus Vinícius Bolívar Malachias
10.1016/j.repce.2019.05.005
Effect of empagliflozin beyond glycemic control: Cardiovascular benefit in patients with type 2 diabetes and established cardiovascular disease
Pedro Monteiro, Carlos Aguiar, Pedro Matos, José Silva-Nunes, Rita Birne, Patrícia Branco, Joaquim Calado, Miguel Melo, Jorge Polónia
10.1016/j.repce.2019.02.015
Does lowering triglycerides reduce cardiovascular risk?
José Pereira de Moura
10.1016/j.repce.2019.11.005